Plus, news about DiaMedica Therapeutics, Cantargia and Quetzal Therapeutics:
Bristol Myers Squibb suffers late-stage miss in anemia: Patients with myelofibrosis-associated anemia taking Reblozyl were no more able than those on placebo to go three months ...
↧